Amytal Sodium and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Amytal Sodium and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: amobarbital
Brand name: Amytal Sodium
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amytal Sodium-Insulin degludec
- Amytal Sodium-Insulin Degludec (U-100) Prefilled Pens
- Amytal Sodium-Insulin Degludec (U-100) Vials
- Amytal Sodium-Insulin Degludec (U-200) Prefilled Pens
- Amytal Sodium-Insulin degludec and liraglutide
- Amytal Sodium-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-An-DTPA
- Insulin aspart, recombinant Subcutaneous-Ana-Lex Cream
- Insulin aspart, recombinant Subcutaneous-Ana-Lex topical/rectal
- Insulin aspart, recombinant Subcutaneous-Anacaine
- Insulin aspart, recombinant Subcutaneous-Anacin
- Insulin aspart, recombinant Subcutaneous-Anacin Advanced Headache Formula